# US 2010/0167281 A1 · Sequence analysis method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0167281 A1
- Document ID: US20100167281A1
- Status: Published application
- Kind: A1
- Application number: 12/389,151
- Filed: 2009-02-19
- Published: 2010-07-01
- Earliest claimed: 2008-07-30
- Inventors: Maiko Tanabe; Chihiro Uematsu; Hirokazu Nishida; Kenko Uchida
- Web page: https://patentgrep.com/patent/US20100167281A1

## CPC

- C12Q 1/6816: characterised by the detection means (C12Q1/6804 takes precedence)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

It is intended to provide an assay for the presence, absence or amount of a nucleic-acid fragment having a certain nucleotide sequence, for example, a polyA length, a difference in the number of repetition of a direct repeat sequence (e.g., microsatellite), single nucleotide substitution (or single nucleotide polymorphism), and nucleotide sequence insertion or deletion, and to provide a genetic testing using the same. The present invention relates to a nucleotide analysis method, comprising: hybridizing at least two probes to a nucleic-acid fragment; ligating the at least two probes using ligase; exchanging, to ATP, pyrophosphoric acid produced through the ligation reaction; and detecting chemiluminescence reaction dependent on the ATP.

## Claims

### Claim 1

A nucleotide analysis method, comprising: hybridizing at least two probes to a nucleic-acid fragment; ligating the at least two probes using ligase; exchanging, to ATP, pyrophosphoric acid produced through the ligation reaction; and detecting chemiluminescence reaction dependent on the ATP.

### Claim 2 (depends on 1)

The nucleotide analysis method according to claim 1, wherein the at least two probes are hybridized to adjacent regions, respectively, in the nucleic-acid fragment.

### Claim 3 (depends on 1)

The nucleotide analysis method according to claim 1, wherein at least one probe of the at least two probes has a 5′-end labeled with a phosphate group.

### Claim 4 (depends on 1)

The nucleotide analysis method according to claim 1, wherein the ligase catalyzes the ligation reaction using a substrate, and the chemiluminescence reaction is catalyzed by luciferase, wherein the substrate is substantially unreactive with the luciferase.

### Claim 5 (depends on 1)

The nucleotide analysis method according to claim 1, wherein the ligase is capable of catalyzing the ligation reaction using the substrate which is substantially unreactive with the luciferase.

### Claim 6 (depends on 1)

The nucleotide analysis method according to claim 1, wherein the chemiluminescence reaction is detected to thereby detect the presence, absence and/or amount of the sequence of interest in the nucleic-acid fragment.

### Claim 7 (depends on 1)

The nucleotide analysis method according to claim 1, wherein the at least two probes are hybridized to RNA or DNA sequence regions, respectively, in the nucleic-acid fragment.

### Claim 8 (depends on 1)

The nucleotide analysis method according to claim 1, wherein the at least two probes are hybridized to an amplified nucleic-acid fragment as the nucleic-acid fragment.

### Claim 9 (depends on 1)

The nucleotide analysis method according to claim 1, wherein the at least two probes each comprise an oligo dT nucleotide.

### Claim 10 (depends on 9)

The nucleotide analysis method according to claim 9, wherein the chemiluminescence reaction is detected to thereby measure the length of the nucleic-acid fragment.

### Claim 11 (depends on 1)

The nucleotide analysis method according to claim 1, wherein the at least two probes are hybridized to direct repeat sequence regions, respectively, in the nucleic-acid fragment.

### Claim 12 (depends on 11)

The nucleotide analysis method according to claim 11, wherein the direct repeat sequence in the nucleic-acid fragment is a particular nucleotide sequence occurring repetitively.

### Claim 13 (depends on 11)

The nucleotide analysis method according to claim 11, wherein the at least two probes each comprise a complementary sequence to the direct repeat sequence.

### Claim 14 (depends on 11)

The nucleotide analysis method according to claim 11, wherein the chemiluminescence reaction is detected to thereby measure the number of repetition of the direct repeat sequence.

### Claim 15 (depends on 1)

The nucleotide analysis method according to claim 1, wherein at least one probe of the at least two probes has an end corresponding to an SNP site in the nucleic-acid fragment.

### Claim 16 (depends on 15)

The nucleotide analysis method according to claim 15, wherein the chemiluminescence reaction is detected to thereby determine the presence or absence of the ligation reaction, based on which the presence or absence of a mutation in the SNP site is determined.

### Claim 17 (depends on 1)

The nucleotide analysis method according to claim 1, wherein the at least two probes are hybridized to regions flanking upstream and downstream of a nucleotide sequence insertion site, respectively, in the nucleic-acid fragment.

### Claim 18 (depends on 17)

The nucleotide analysis method according to claim 17, wherein the chemiluminescence reaction is detected to thereby determine the presence or absence of the ligation reaction, based on which the presence or absence of a mutation in the nucleotide sequence insertion site is determined.

### Claim 19 (depends on 1)

The nucleotide analysis method according to claim 1, wherein at least one probe of the at least two probes has an end corresponding to a nucleotide sequence deletion site in the nucleic-acid fragment.

### Claim 20 (depends on 19)

The nucleotide analysis method according to claim 19, wherein the chemiluminescence reaction is detected to thereby determine the presence or absence of the ligation reaction, based on which the presence or absence of a mutation in the nucleotide sequence deletion site is determined.
